 Alliancebernstein L.P. boosted its holdings in shares of Crinetics Pharmaceuticals Inc NASDAQ:CRNX by 5.4 in the 4th quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The firm owned 11,800 shares of the companys stock after buying an additional 600 shares during the quarter. Alliancebernstein L.P.s holdings in Crinetics ... 